Qual é o preço para Novartis AG (NVS)

O preço para Novartis AG (NVS) é $150.75

Qual é a capitalização de mercado para Novartis AG (NVS)

A capitalização de mercado para Novartis AG (NVS) é $291.41B

Lucros de Novartis AG (NVS)

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Ano	Lucros	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Lucros

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Lucros	Diferença de Lucros	País
Eli Lilly LLY.US	$25.73B	-	US
AstraZeneca PLC AZN.US	$12.40B	-	GB
Johnson & Johnson JNJ.US	$32.58B	-	US
AbbVie Inc. ABBV.US	$6.60B	-	US
Merck & Co., Inc. MRK.US	$21.07B	-	US

Empresa

Lucros

Diferença de Lucros

País